Top Cancer Stocks in Australia
Browse the largest Australia companies in the world ranked by their Market Capitalization. Global Cancer Companies in Australia market cap is $4.86B.
13 Nov 2024, 13:33 UTC
Companies: 11
🇦🇺1 |  | $12.63 | 4.59% | 4.09B | 84.85% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺2 |  | $0.03 | 6.25% | 217.72M | -53.64% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺3 |  | $0.24 | 0.72% | 209.80M | -0.71% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺4 |  | $0.11 | 3.23% | 77.01M | 33.33% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺5 |  | $0.12 | 3.03% | 36.92M | 47.83% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺6 |  | $0.34 | 0.00% | 31.09M | -25.93% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺7 |  | $0.07 | 0.00% | 19.75M | 35.14% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺8 |  | $0.01 | -3.70% | 17.37M | 44.44% | Outperform S&P500 YTD Benchamark | 🩹 Medical devices | - |
🇦🇺9 |  | $0.02 | 3.23% | 14.19M | 60.00% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺10 |  | $0.00 | 0.00% | 13.03M | -40.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺11 |  | $0.00 | -14.29% | 8.34M | -25.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
